| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.52B | 66.96B | 65.40B | 59.98B | 55.70B | 52.66B |
| Gross Profit | 20.10B | 20.58B | 19.72B | 16.77B | 16.30B | 18.10B |
| EBITDA | 14.49B | 14.03B | 14.24B | 12.85B | 11.20B | 12.99B |
| Net Income | 8.74B | 9.46B | 8.21B | 7.35B | 6.38B | 7.71B |
Balance Sheet | ||||||
| Total Assets | 144.50B | 151.05B | 145.73B | 136.60B | 126.26B | 119.96B |
| Cash, Cash Equivalents and Short-Term Investments | 56.24B | 53.64B | 58.96B | 50.21B | 56.80B | 64.90B |
| Total Debt | 15.86M | 9.77M | 18.03M | 26.27M | 34.43M | 42.87M |
| Total Liabilities | 17.51B | 16.30B | 17.35B | 16.32B | 14.52B | 13.63B |
| Stockholders Equity | 125.77B | 133.33B | 127.10B | 119.18B | 110.76B | 105.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.74B | 11.21B | 5.76B | 2.57B | 5.93B |
| Operating Cash Flow | 0.00 | 9.06B | 12.17B | 8.81B | 5.60B | 8.30B |
| Investing Cash Flow | 0.00 | -9.96B | 675.47M | -14.50B | -1.92B | 7.06B |
| Financing Cash Flow | 0.00 | -5.45B | -3.54B | -3.28B | -3.09B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥175.17B | 18.86 | 7.21% | 3.24% | 2.38% | 15.25% | |
71 Outperform | ¥4.74T | 23.62 | 9.46% | 1.32% | 3.47% | 99.65% | |
71 Outperform | ¥1.39T | 21.75 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥575.76B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
66 Neutral | ¥130.99B | 24.96 | ― | 1.08% | 4.45% | 11.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥341.86B | 38.25 | 4.15% | 1.66% | 0.49% | -39.52% |